We use science to inform the development, evaluation, and implementation of digital tools for behavioral health.
Research Studies
State of the art technologies and interventions, rigorous evaluation of interventions, and improvement of research and implementation methodologies.
Program Reviews
Synthesizing current research on digital health technologies for substance use disorders and co-occurring conditions.
Research Tools
The latest resources and best practice guidelines to assist researchers in studying digital health technologies.
About CTBH
CTBH is organized into five cores: Treatment Development & Evaluation, Emerging Technologies & Data Analytics, Dissemination & Implementation, Pilot and Administrative. Core activities focus on identifying and studying state-of-the-art issues related to digital therapeutics for behavioral health.
Recent Center Highlights
- CTBH in the News! Lynn Fiellin and the play2PREVENT Lab publish results of PlaySmart clinical trial Learn More
- CTBH in the News! Michael Heinz and Nick Jacobson discuss Therabot, an AI chatbot for mental health Learn More
- CTBH in the News! Michael Heinz quoted on the promise of Therabot, AI-driven digital therapeutic solutions Learn More
Eye on Innovation
- How AI Is Changing the Way People Think About Mental Health Support
Article Excerpt: In a 2025 clinical trial involving 106 adults, Dartmouth researchers found significant symptom improvements among participants using a purpose-built gene ...
- Prediction of Relapse Using Digital Technology in People in Recovery from Substance Use Disorders: Early Economic Evaluation with a Case Study of the Subreal App.
Bouttell J, Bartler M, Bolton S. Prediction of Relapse Using Digital Technology in People in Recovery From Substance Use Disorders: Early Economic Evaluation With a Case ...
- Inside Evergreen and Therabot with psychiatry and computer science professor Nicholas Jacobson
Article Excerpt: Over a year after artificial intelligence therapy chatbot Therabot’s first clinical trial on March 27, 2025, The Dartmouth sat down with biomedical dat ...